SCHEMBL769154

SCHEMBL769154

CCCCCCCC/C=C\CCCCCCCC(=O)OC(O)CC

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKCA P17252 2/20 0.59
PRKCE Q02156 1/20 0.59
PRKCQ Q04759 1/20 0.59
PRKCD Q05655 1/20 0.59
DGKA P23743 1/20 0.58
FAAH O00519 3/20 0.56
MAPT P10636 3/20 0.56
ALDH1A1 P00352 1/20 0.56
HPGD P15428 1/20 0.56
CNR1 P21554 1/20 0.56
CNR2 P34972 1/20 0.56
LMNA P02545 3/20 0.54
TERT O14746 3/20 0.54
PTPN1 P18031 3/20 0.54
CYP1A2 P05177 2/20 0.54
CYP2C19 P33261 2/20 0.54
BLM P54132 2/20 0.54
HSD17B10 Q99714 2/20 0.54
FABP4 P15090 2/20 0.54
PPARG P37231 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3658519 1.00 PRKCA (0.59) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL3657904 1.00 PRKCA (0.59) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL3660035 0.95 ALDH1A1 (0.63) PRKCAPRKCEPRKCQPRKCDFAAH
SCHEMBL3028731 0.90 LMNA (0.66) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL545424 0.90 LMNA (0.66) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL3930992 0.90 LMNA (0.66) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL3720851 0.90 LMNA (0.66) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL769294 0.90 LMNA (0.66) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL27469007 0.90 LMNA (0.66) PRKCAPRKCEPRKCQPRKCDDGKA
SCHEMBL770066 0.90 LMNA (0.66) PRKCAPRKCEPRKCQPRKCDDGKA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8425784-B2 Ozonolysis reactions in liquid CO2 and CO2-expanded solvents UNIVERSITY OF KANSAS (US) 2013-04-23 US claimed
EP-2209547-B1 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS UNIV KANSAS (US) 2018-06-20 EP disclosed
US-9668951-B2 Pharmaceutical compositions comprising renewably-based biodegradable 1,3-propanediol DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2017-06-06 US disclosed
EP-2393469-B1 Process of treating hair RHODIA OPERATIONS (FR) 2016-10-12 EP disclosed
US-9375390-B2 Agricultural compositions comprising renewably-based biodegradable 1,3-propanediol DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2016-06-28 US disclosed
US-20140326923-A1 Agricultural Compositions Comprising Renewably-Based Biodegradable 1,3-Propanediol DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2014-11-06 US disclosed
US-20140328938-A1 Pharmaceutical Compositions Comprising Renewably-Based Biodegradable 1,3-Propanediol DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2014-11-06 US disclosed
CN-101909729-B Ozonolysis reactions in liquid CO2 and CO2-expanded solvents UNIVERSITY OF KANSAS (US) 2014-10-22 CN disclosed
US-8801939-B2 Ozonolysis reactions in liquid CO2 and CO2-expanded solvents UNIVERSITY OF KANSAS (US) 2014-08-12 US disclosed
US-8802729-B2 Enzyme stabilized detergent compositions DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2014-08-12 US disclosed
US-20120071390-A1 DETERGENT COMPOSITION CONTAINING BIO-DERIVED 1,3-PROPANEDIOL AND ITS CONJUGATE ESTERS BARCLAYS BANK PLC, AS COLLATERAL AGENT 2012-03-22 US disclosed
US-8048920-B2 Personal care composition containing bio-derived 1,3-propanediol and its conjugate esters DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2011-11-01 US disclosed
EP-2209547-A2 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS University Of Kansas (US) 2010-07-28 EP disclosed
US-20100034761-A1 PERSONAL CARE AND COSMETICS COMPOSITIONS COMPRISING BIOLOGICALLY-BASED MONO AND DI ESTERS BARCLAYS BANK PLC, AS COLLATERAL AGENT 2010-02-11 US disclosed
WO-2009061806-A2 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS UNIVERSITY OF KANSAS (US) 2009-05-14 WO disclosed
US-20090118498-A1 OZONOLYSIS REACTIONS IN LIQUID CO2 AND CO2-EXPANDED SOLVENTS ARCHER DANIELS MIDLAND COMPANY 2009-05-07 US disclosed
EP-2007210-A2 COMPOSITIONS COMPRISING MONO AND DI ESTERS OF BIOLOGICALLY-BASED 1.3-PROPANEDIOL DuPont Tate & Lyle Bio Products Company, LLC (US) 2008-12-31 EP disclosed
WO-2008123845-A2 COMPOSITIONS COMPRISING MONO AND DI ESTERS OF BIOLOGICALLY-BASED 1.3-PROPANEDIOL DUPONT TATE & LYLE BIO PRODUCTS COMPANY, LLC (US) 2008-10-16 WO disclosed
US-20070202073-A1 Personal care and cosmetics compositions comprising biologically-based mono and di esters DUPONT TATE &LYLE BIO PRODUCTS COMPANY, LLC 2007-08-30 US disclosed
US-4364743-A ESTER AND MIDDLE OIL ERNER WILLIAM E 1982-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120071390-A1 DETERGENT COMPOSITION CONTAINING BIO-DERIVED 1,3-PROPANEDIOL AND ITS CONJUGATE ESTERS PHOSPHO1, ABHD11, DEGS1 PRKCA 1464/4885PRKCE 1070/4885PRKCQ 1150/4885
US-20140328938-A1 Pharmaceutical Compositions Comprising Renewably-Based Biodegradable 1,3-Propanediol PGD, PHGDH, CYP3A43 PRKCA 2366/4885PRKCE 2132/4885PRKCQ 2787/4885
US-20140326923-A1 Agricultural Compositions Comprising Renewably-Based Biodegradable 1,3-Propanediol PGD, PHGDH, HPD PRKCA 2014/4885PRKCE 1971/4885PRKCQ 2520/4885
US-20100034761-A1 PERSONAL CARE AND COSMETICS COMPOSITIONS COMPRISING BIOLOGICALLY-BASED MONO AND DI ESTERS PBDC1, CUTA, EBP PRKCA 751/4885PRKCE 715/4885PRKCQ 1193/4885
US-20070202073-A1 Personal care and cosmetics compositions comprising biologically-based mono and di esters PBDC1, CUTA, EBP PRKCA 751/4885PRKCE 715/4885PRKCQ 1193/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.